Page last updated: 2024-10-19

nitrites and Injury, Myocardial Reperfusion

nitrites has been researched along with Injury, Myocardial Reperfusion in 75 studies

Nitrites: Salts of nitrous acid or compounds containing the group NO2-. The inorganic nitrites of the type MNO2 (where M=metal) are all insoluble, except the alkali nitrites. The organic nitrites may be isomeric, but not identical with the corresponding nitro compounds. (Grant & Hackh's Chemical Dictionary, 5th ed)

Research Excerpts

ExcerptRelevanceReference
"Compared with controls, sodium nitrite administered either pre-occlusion or pre-reperfusion markedly suppressed the number and severity of ventricular arrhythmias during occlusion and increased survival (0% vs."7.81Effect of sodium nitrite on ischaemia and reperfusion-induced arrhythmias in anaesthetized dogs: is protein S-nitrosylation involved? ( Gönczi, M; Kaszaki, J; Kiss, A; Kohr, MJ; Kovács, M; Miskolczi, G; Murphy, E; Seprényi, G; Végh, Á, 2015)
"Obesity is a major risk factor for coronary artery disease, but its impact on anesthetic-induced cardioprotective actions is unexplored."5.37Diet-induced obesity suppresses sevoflurane preconditioning against myocardial ischemia-reperfusion injury: role of AMP-activated protein kinase pathway. ( Cui, WY; Lv, LY; Qu, G; Shi, XM; Song, T; Tian, ZY; Wang, QS; Xu, J, 2011)
"Treatment with hesperidin showed a significant increase in tissue nitrite, antioxidant level and reduction in inflammation, arrhythmias and apoptosis."5.35Protection against in vivo focal myocardial ischemia/reperfusion injury-induced arrhythmias and apoptosis by hesperidin. ( Balaraman, R; Gandhi, C; Upaganalawar, A, 2009)
"Compared with controls, sodium nitrite administered either pre-occlusion or pre-reperfusion markedly suppressed the number and severity of ventricular arrhythmias during occlusion and increased survival (0% vs."3.81Effect of sodium nitrite on ischaemia and reperfusion-induced arrhythmias in anaesthetized dogs: is protein S-nitrosylation involved? ( Gönczi, M; Kaszaki, J; Kiss, A; Kohr, MJ; Kovács, M; Miskolczi, G; Murphy, E; Seprényi, G; Végh, Á, 2015)
" Severities of ischaemia (ST-segment elevation, inhomogeneity of electrical activation) and ventricular arrhythmias (VPBs, VT, VF), plasma nitrate/nitrite levels, as well as myocardial superoxide and nitrotyrosine productions were determined."3.77Is there a trigger role of peroxynitrite in the anti-arrhythmic effect of ischaemic preconditioning and peroxynitrite infusion? ( Juhász, L; Kaszaki, J; Kiss, A; Kovács, M; Nyeso, E; Seprényi, G; Végh, A, 2011)
"Inhibition of arginase protects from myocardial infarction by a mechanism that is dependent on NOS activity and bioavailability of NO by shifting arginine utilization from arginase towards NOS."3.76Arginase inhibition mediates cardioprotection during ischaemia-reperfusion. ( Gonon, AT; Jung, C; Lundberg, JO; Pernow, J; Sjöquist, PO, 2010)
"Previous studies indicate that adenosine supplementation or nitric oxide synthase (NOS) inhibition during reperfusion exert protective effects against myocardial ischemia-reperfusion (I/R) injury."3.74Delayed 24 hours Nomega-nitro-L-arginine methyl ester injection induces pharmacological cardioprotection against reperfusion injury. ( Bouhaddi, M; Davani, S; Kantelip, JP; Reyssie, H; Rochette, L; Royer, B; Vergely, C, 2007)
"Peritonitis sepsis induced multiple organ dysfunction, mitochondrial abnormalities, and increased mortality rate, which were reduced by pharmacological inhibition of mitochondrial transition by cyclosporine derivatives and mitochondrial Bcl-2 overexpression."3.73Inhibition of mitochondrial permeability transition prevents sepsis-induced myocardial dysfunction and mortality. ( Chopin, C; Decoster, B; Favory, R; Hassoun, SM; Lancel, S; Larche, J; Marchetti, P; Neviere, R, 2006)
") is thought to protect against the damaging effects of myocardial ischemia-reperfusion injury, whereas xanthine oxidoreductase (XOR) normally causes damage through the generation of reactive oxygen species."3.72Reduction of nitrite to nitric oxide during ischemia protects against myocardial ischemia-reperfusion damage. ( Ahluwalia, A; Benjamin, N; Bond, R; McLean, P; Uppal, R; Webb, A, 2004)
"Obesity is a major risk factor for coronary artery disease, but its impact on anesthetic-induced cardioprotective actions is unexplored."1.37Diet-induced obesity suppresses sevoflurane preconditioning against myocardial ischemia-reperfusion injury: role of AMP-activated protein kinase pathway. ( Cui, WY; Lv, LY; Qu, G; Shi, XM; Song, T; Tian, ZY; Wang, QS; Xu, J, 2011)
"Hyperglycemia is known to inhibit ischemic and anesthetic preconditioning."1.36Hyperglycemia inhibits anesthetic-induced postconditioning in the rabbit heart via modulation of phosphatidylinositol-3-kinase/Akt and endothelial nitric oxide synthase signaling. ( Gozal, Y; Navot, N; Raphael, J; Zuo, Z, 2010)
"Treatment with hesperidin showed a significant increase in tissue nitrite, antioxidant level and reduction in inflammation, arrhythmias and apoptosis."1.35Protection against in vivo focal myocardial ischemia/reperfusion injury-induced arrhythmias and apoptosis by hesperidin. ( Balaraman, R; Gandhi, C; Upaganalawar, A, 2009)
"085 DV."1.29Polydeoxyribonucleotides and nitric oxide release from guinea-pig hearts during ischaemia and reperfusion. ( Lupini, M; Mannaioni, PF; Masini, E; Mugnai, L; Raspanti, S, 1995)

Research

Studies (75)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's8 (10.67)18.2507
2000's29 (38.67)29.6817
2010's33 (44.00)24.3611
2020's5 (6.67)2.80

Authors

AuthorsStudies
Yassaghi, Y1
Jeddi, S2
Yousefzadeh, N1
Kashfi, K1
Ghasemi, A2
Liu, Y1
Croft, KD1
Hodgson, JM1
Mori, T1
Ward, NC1
Koka, S1
Xi, L1
Kukreja, RC1
Rajani, SF1
Faghihi, M1
Imani, A1
Griffiths, K1
Lee, JJ1
Frenneaux, MP1
Feelisch, M5
Madhani, M1
Totzeck, M2
Korste, S1
Miinalainen, I1
Hendgen-Cotta, UB3
Rassaf, T5
Cahuê, F1
Souza, S1
Dos Santos, CFM1
Machado, V1
Nascimento, JHM1
Barcellos, L1
Salerno, VP1
Vishwakarma, VK1
Goyal, A2
Gupta, JK2
Upadhyay, PK1
Yadav, HN2
Yellon, DM2
He, Z1
Khambata, R1
Ahluwalia, A2
Davidson, SM1
Erkens, R1
Suvorava, T1
Sutton, TR1
Fernandez, BO3
Mikus-Lelinska, M1
Barbarino, F1
Flögel, U1
Kelm, M3
Cortese-Krott, MM1
Nagasaka, Y1
Steinbicker, AU1
Spagnolli, E1
Malhotra, R1
Bloch, DB1
Bloch, KD1
Zapol, WM1
Inserte, J1
Hernando, V1
Vilardosa, Ú1
Abad, E1
Poncelas-Nozal, M1
Garcia-Dorado, D2
Sobierajski, J1
Pagliaro, P1
Gattullo, D1
Penna, C1
Ferdinandy, P1
Schulz, R1
Nicholson, CK2
Lambert, JP1
Chow, CW1
Lefer, DJ6
Calvert, JW5
Yang, J1
Gonon, AT2
Sjöquist, PO2
Lundberg, JO3
Pernow, J2
Toropova, IaG1
Antonova, LV1
Mukhamadiiarov, RA1
Bogdanov, MV1
Golovkin, AS1
Kovács, M2
Kiss, A2
Gönczi, M1
Miskolczi, G1
Seprényi, G2
Kaszaki, J2
Kohr, MJ1
Murphy, E1
Végh, Á2
Naryzhnaya, NV1
Maslov, LN1
Tsibulnikov, SY1
Prokudina, ES1
Lishmanov, YB1
Charan, K1
Zaman, J1
Hausenloy, DJ1
Botker, HE1
Engstrom, T1
Erlinge, D1
Heusch, G1
Ibanez, B1
Kloner, RA1
Ovize, M1
Valle Raleigh, J1
Mauro, AG1
Devarakonda, T1
Marchetti, C1
He, J1
Kim, E1
Filippone, S1
Das, A1
Toldo, S1
Abbate, A1
Salloum, FN1
Merx, MW1
Shiva, S5
Schmitz, J1
Becher, S1
Klare, JP1
Steinhoff, HJ1
Goedecke, A1
Schrader, J1
Gladwin, MT5
Sinha, SS1
McNulty, PH1
Scott, S1
Kehoe, V1
Kozak, M1
Sinoway, LI1
Li, J1
Tsikas, D1
Rossi, R1
Gandhi, C1
Upaganalawar, A1
Balaraman, R1
Jung, C1
Weitzberg, E1
Lim, CC1
Bryan, NS2
Jain, M1
Garcia-Saura, MF1
Sawyer, DB1
Handy, DE1
Loscalzo, J1
Liao, R1
Milano, G1
Corno, AF1
Samaja, M1
Morel, S1
Vassalli, G1
von Segesser, LK1
Iliodromitis, EK2
Andreadou, I2
Prokovas, E1
Zoga, A2
Farmakis, D2
Fotopoulou, T1
Ioannidis, K1
Paraskevaidis, IA1
Kremastinos, DT2
Raphael, J1
Gozal, Y1
Navot, N1
Zuo, Z1
Di Filippo, C1
Monopoli, A1
Ongini, E1
Perretti, M1
D'Amico, M1
Wang, E1
Feng, Y1
Zhang, M1
Zou, L1
Li, Y1
Buys, ES1
Huang, P1
Brouckaert, P1
Chao, W1
Condit, ME1
Aragón, JP1
Moody, BF1
Hood, RL1
Sindler, AL1
Gundewar, S2
Seals, DR1
Barouch, LA1
Bezzerides, V1
Rosenzweig, A1
Juhász, L1
Nyeso, E1
Song, T1
Lv, LY1
Xu, J1
Tian, ZY1
Cui, WY1
Wang, QS1
Qu, G1
Shi, XM1
Neye, N1
Enigk, F1
Habazettl, H1
Plesnila, N1
Kuppe, H1
Kuebler, WM1
Pisarenko, OI1
Serebryakova, LI1
Pelogeykina, YA1
Studneva, IM1
Khatri, DN1
Tskitishvili, OV1
Bespalova, ZhD1
Az'muko, AA1
Sidorova, MV1
Pal'keeva, ME1
Demerouti, E1
Aggeli, IK1
Gaitanaki, C1
Beis, I1
Anastasiou-Nana, M1
Maczewski, M1
Beresewicz, A1
Sharma, M1
Ganguly, NK1
Chaturvedi, G1
Thingnam, SK1
Majumdar, S1
Suri, RK1
Webb, A1
Bond, R1
McLean, P1
Uppal, R1
Benjamin, N1
Ding, HL1
Zhu, HF1
Dong, JW1
Zhu, WZ1
Yang, WW1
Yang, HT1
Zhou, ZN1
Di Napoli, P2
Taccardi, AA1
Grilli, A2
De Lutiis, MA1
Barsotti, A2
Felaco, M2
De Caterina, R2
Kuralay, F1
Altekin, E1
Yazlar, AS1
Onvural, B1
Goldeli, O1
Larche, J1
Lancel, S1
Hassoun, SM1
Favory, R1
Decoster, B1
Marchetti, P1
Chopin, C1
Neviere, R1
De Gennaro Colonna, V1
Bonomo, S1
Ferrario, P1
Bianchi, M1
Berti, M1
Guazzi, M1
Manfredi, B1
Muller, EE1
Berti, F1
Rossoni, G1
Davani, S1
Vergely, C1
Royer, B1
Bouhaddi, M1
Reyssie, H1
Rochette, L1
Kantelip, JP1
Sack, MN2
Greer, JJ1
Duranski, M1
Ringwood, LA1
Burwell, L1
Wang, X1
MacArthur, PH1
Shoja, A1
Raghavachari, N1
Brookes, PS1
Chen, CH1
Liu, K1
Chan, JY1
Elrod, JW1
Ji, SY1
Schwartz, DR1
Masini, E1
Lupini, M1
Mugnai, L1
Raspanti, S1
Mannaioni, PF1
Zweier, JL1
Wang, P1
Samouilov, A1
Kuppusamy, P1
van Jaarsveld, H1
Schulenburg, DH1
Kouretas, PC1
Kim, YD1
Cahill, PA1
Myers, AK1
To, LN1
Wang, YN1
Sitzmann, JV1
Hannan, RL1
Parikh, V2
Singh, M2
Ma, XL1
Gao, F1
Liu, GL1
Lopez, BL1
Christopher, TA1
Fukuto, JM1
Wink, DA1
Shen, JG1
Quo, XS1
Jiang, B1
Li, M1
Xin, W1
Zhao, BL1
Hayakawa, M1
Ito, T1
Osanai, H1
Harada, M1
Numaguchi, Y1
Mokuno, S1
Murase, K1
Toki, Y1
Okumura, K1
Hayakawa, T1
Zhai, P1
Eurell, TE1
Cotthaus, R1
Jeffery, EH1
Bahr, JM1
Gross, DR1
Hung, LM1
Chen, JK1
Lee, RS1
Liang, HC1
Su, MJ1
Antonio Taccardi, A1
Spina, R1
Johnson, G2
Tsao, PS1
Mulloy, D1
Lefer, AM2
Tsao, P1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Cardioprotective Effect of Dexmedetomidine in Patients With ST-segment Elevation Myocardial Infarction: a Double-Blind, Multicenter, Randomized, Placebo-Controlled Clinical Trial[NCT04912518]250 participants (Anticipated)Interventional2021-05-27Recruiting
The Role of Nitrite in Preconditioning Mediated Tolerance to Ischemic Stress[NCT00250185]Phase 1135 participants Interventional2005-11-01Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

12 reviews available for nitrites and Injury, Myocardial Reperfusion

ArticleYear
Mechanisms of the protective effects of nitrate and nitrite in cardiovascular and metabolic diseases.
    Nitric oxide : biology and chemistry, 2020, 03-01, Volume: 96

    Topics: Animals; Blood Pressure; Diabetes Mellitus; Endothelium, Vascular; Humans; Hypertension, Pulmonary;

2020
Nitrite and myocardial ischaemia reperfusion injury. Where are we now?
    Pharmacology & therapeutics, 2021, Volume: 223

    Topics: Cardiotonic Agents; Clinical Trials as Topic; Humans; Myocardial Reperfusion Injury; Nitrites

2021
Nitrite-Nitric Oxide Signaling and Cardioprotection.
    Advances in experimental medicine and biology, 2017, Volume: 982

    Topics: Animals; Cytoprotection; Humans; Ischemic Preconditioning, Myocardial; Mitochondria, Heart; Myocardi

2017
[New strategies in cardioprotection during acute myocardial infarction: Impact of hypoxic nitrate-nitrite-NO signaling].
    Deutsche medizinische Wochenschrift (1946), 2013, Volume: 138, Issue:15

    Topics: Animals; Humans; Models, Cardiovascular; Myocardial Infarction; Myocardial Reperfusion Injury; Nitra

2013
Nitroglycerine and sodium trioxodinitrate: from the discovery to the preconditioning effect.
    Journal of cardiovascular medicine (Hagerstown, Md.), 2013, Volume: 14, Issue:10

    Topics: Animals; Cardiovascular Agents; History, 19th Century; History, 20th Century; Humans; Myocardial Rep

2013
Nitrite in organ protection.
    British journal of pharmacology, 2014, Volume: 171, Issue:1

    Topics: Animals; Cytoprotection; Humans; Myocardial Reperfusion Injury; Nitrates; Nitric Oxide; Nitrites; Pr

2014
Myocardial protection by nitrite: evidence that this reperfusion therapeutic will not be lost in translation.
    Trends in cardiovascular medicine, 2008, Volume: 18, Issue:5

    Topics: Animals; Clinical Trials as Topic; Cytoprotection; Hemoglobins; Humans; Myocardial Infarction; Myoca

2008
Nitrite mediates cytoprotection after ischemia/reperfusion by modulating mitochondrial function.
    Basic research in cardiology, 2009, Volume: 104, Issue:2

    Topics: Animals; Cytoprotection; Electron Transport Complex I; Humans; Mitochondria, Heart; Myocardial Reper

2009
Myocardial protection by nitrite.
    Cardiovascular research, 2009, Jul-15, Volume: 83, Issue:2

    Topics: Animals; Cytoprotection; Homeostasis; Humans; Myocardial Infarction; Myocardial Reperfusion Injury;

2009
NO generation from inorganic nitrate and nitrite: Role in physiology, nutrition and therapeutics.
    Archives of pharmacal research, 2009, Volume: 32, Issue:8

    Topics: Animals; Humans; Myocardial Reperfusion Injury; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitri

2009
Emerging role of nitrite in myocardial protection.
    Archives of pharmacal research, 2009, Volume: 32, Issue:8

    Topics: Animals; Cardiovascular Diseases; Cytoprotection; Homeostasis; Humans; Myocardial Reperfusion Injury

2009
Targeting the mitochondria to augment myocardial protection.
    Current opinion in pharmacology, 2008, Volume: 8, Issue:2

    Topics: AMP-Activated Protein Kinases; Animals; Antioxidants; Drug Delivery Systems; Homeostasis; Humans; Is

2008

Other Studies

63 other studies available for nitrites and Injury, Myocardial Reperfusion

ArticleYear
Long-term inorganic nitrate administration protects against myocardial ischemia-reperfusion injury in female rats.
    BMC cardiovascular disorders, 2023, 08-21, Volume: 23, Issue:1

    Topics: Animals; Female; Male; Myocardial Reperfusion Injury; Nitrates; Nitric Oxide; Nitrites; Progesterone

2023
Chronic inhibition of phosphodiesterase 5 with tadalafil affords cardioprotection in a mouse model of metabolic syndrome: role of nitric oxide.
    Molecular and cellular biochemistry, 2020, Volume: 468, Issue:1-2

    Topics: Animals; Cardiotonic Agents; Disease Models, Animal; Dyslipidemias; Heart; Insulin Resistance; Male;

2020
Post-infarct morphine treatment reduces apoptosis and myofibroblast density in a rat model of cardiac ischemia-reperfusion.
    European journal of pharmacology, 2020, Nov-15, Volume: 887

    Topics: Analgesics, Opioid; Animals; Antioxidants; Apoptosis; Coronary Vessels; Fibroblasts; Gelatinases; Li

2020
S-nitrosation of calpains is associated with cardioprotection in myocardial I/R injury.
    Nitric oxide : biology and chemistry, 2017, Jul-01, Volume: 67

    Topics: Animals; Calpain; Cell Line; Male; Mice, Inbred C57BL; Mitochondria; Myocardial Infarction; Myocardi

2017
Short-term consumption of Ilex paraguariensis extracts protects isolated hearts from ischemia/reperfusion injury and contradicts exercise-mediated cardioprotection.
    Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme, 2017, Volume: 42, Issue:11

    Topics: Animals; Blood Pressure; Glutathione; Heart; Ilex paraguariensis; Lipid Peroxidation; Male; Myocardi

2017
Involvement of atrial natriuretic peptide in abrogated cardioprotective effect of ischemic preconditioning in ovariectomized rat heart.
    Human & experimental toxicology, 2018, Volume: 37, Issue:7

    Topics: Animals; Atrial Natriuretic Factor; Cardiotonic Agents; Creatine Kinase, MB Form; Female; Ischemic P

2018
The GTN patch: a simple and effective new approach to cardioprotection?
    Basic research in cardiology, 2018, 04-17, Volume: 113, Issue:3

    Topics: Administration, Cutaneous; Animals; Blood Pressure; Disease Models, Animal; Male; Mice, Inbred C57BL

2018
Nrf2 Deficiency Unmasks the Significance of Nitric Oxide Synthase Activity for Cardioprotection.
    Oxidative medicine and cellular longevity, 2018, Volume: 2018

    Topics: Animals; Aorta; Cardiomegaly; Glutathione; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Repe

2018
Pharmacological preconditioning with inhaled nitric oxide (NO): Organ-specific differences in the lifetime of blood and tissue NO metabolites.
    Nitric oxide : biology and chemistry, 2018, 11-01, Volume: 80

    Topics: Administration, Inhalation; Animals; Brain; Feasibility Studies; Freezing; Half-Life; Kidney; Lung;

2018
Activation of cGMP/protein kinase G pathway in postconditioned myocardium depends on reduced oxidative stress and preserved endothelial nitric oxide synthase coupling.
    Journal of the American Heart Association, 2013, Jan-02, Volume: 2, Issue:1

    Topics: Animals; Biopterins; Cell Death; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Disease Models, A

2013
Chronic exercise downregulates myocardial myoglobin and attenuates nitrite reductase capacity during ischemia-reperfusion.
    Journal of molecular and cellular cardiology, 2013, Volume: 64

    Topics: Animals; Cardiotonic Agents; Carrier Proteins; Disease Models, Animal; Enzyme Activation; Gene Expre

2013
Arginase regulates red blood cell nitric oxide synthase and export of cardioprotective nitric oxide bioactivity.
    Proceedings of the National Academy of Sciences of the United States of America, 2013, Sep-10, Volume: 110, Issue:37

    Topics: Animals; Arginase; Arginine; Biological Transport, Active; Cardiotonic Agents; Enzyme Inhibitors; Er

2013
[Mechanisms of coronary flow recovery in the isolated heart during reperfusion with cardioprotective liposomal emoxipin form].
    Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova, 2013, Volume: 99, Issue:6

    Topics: Animals; Anti-Arrhythmia Agents; Blood Flow Velocity; Coronary Circulation; Heart; In Vitro Techniqu

2013
Effect of sodium nitrite on ischaemia and reperfusion-induced arrhythmias in anaesthetized dogs: is protein S-nitrosylation involved?
    PloS one, 2015, Volume: 10, Issue:4

    Topics: Administration, Intravenous; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disease Models,

2015
[INVOLVEMENT OF NO-SYNTHASE IN THE INFARCT REDUCING EFFECT OF CONTINUOUS CHRONIC NORMOBARTC HYPOXTA].
    Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova, 2015, Volume: 101, Issue:8

    Topics: Animals; Hypoxia; Ischemic Preconditioning, Myocardial; Isothiuronium; Male; Myocardial Infarction;

2015
Role of atrial natriuretic peptide in ischemic preconditioning-induced cardioprotection in the diabetic rat heart.
    The Journal of surgical research, 2016, Volume: 201, Issue:2

    Topics: Alloxan; Animals; Atrial Natriuretic Factor; Blood Glucose; Diabetes Mellitus, Experimental; Drug Ev

2016
Effect of fetal hypothyroidism on tolerance to ischemia-reperfusion injury in aged male rats: Role of nitric oxide.
    Nitric oxide : biology and chemistry, 2016, 05-01, Volume: 55-56

    Topics: Aging; Animals; bcl-2-Associated X Protein; Congenital Hypothyroidism; Creatine Kinase; L-Lactate De

2016
Targeting reperfusion injury in patients with ST-segment elevation myocardial infarction: trials and tribulations.
    European heart journal, 2017, 04-01, Volume: 38, Issue:13

    Topics: Adenosine; Cardiotonic Agents; Clinical Trials as Topic; Combined Modality Therapy; Coronary Vessels

2017
Reperfusion therapy with recombinant human relaxin-2 (Serelaxin) attenuates myocardial infarct size and NLRP3 inflammasome following ischemia/reperfusion injury via eNOS-dependent mechanism.
    Cardiovascular research, 2017, May-01, Volume: 113, Issue:6

    Topics: Animals; Cardiovascular Agents; Caspase 1; Cells, Cultured; Disease Models, Animal; Inflammasomes; M

2017
Nitrite reductase activity of myoglobin regulates respiration and cellular viability in myocardial ischemia-reperfusion injury.
    Proceedings of the National Academy of Sciences of the United States of America, 2008, Jul-22, Volume: 105, Issue:29

    Topics: Aconitate Hydratase; Animals; Cell Respiration; Cell Survival; Heme; In Vitro Techniques; Male; Mice

2008
Nitrite consumption in ischemic rat heart catalyzed by distinct blood-borne and tissue factors.
    American journal of physiology. Heart and circulatory physiology, 2008, Volume: 295, Issue:5

    Topics: Allopurinol; Animals; Catalysis; Disease Models, Animal; Enzyme Inhibitors; Erythrocytes; Glucose; G

2008
Letter by Tsikas and Rossi regarding article, "Nitrite anion provides potent cytoprotective and antiapoptotic effects as adjunctive therapy to reperfusion for acute myocardial infarction".
    Circulation, 2009, May-19, Volume: 119, Issue:19

    Topics: Animals; Apoptosis; Cardiotonic Agents; Combined Modality Therapy; Cytoprotection; Dogs; Erythrocyte

2009
Protection against in vivo focal myocardial ischemia/reperfusion injury-induced arrhythmias and apoptosis by hesperidin.
    Free radical research, 2009, Volume: 43, Issue:9

    Topics: Animals; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Arrhythmias, Car

2009
Arginase inhibition mediates cardioprotection during ischaemia-reperfusion.
    Cardiovascular research, 2010, Jan-01, Volume: 85, Issue:1

    Topics: Amino Acids; Animals; Arginase; Arginine; Blood Pressure; Enzyme Inhibitors; Heart Rate; Male; Myoca

2010
Glutathione peroxidase deficiency exacerbates ischemia-reperfusion injury in male but not female myocardium: insights into antioxidant compensatory mechanisms.
    American journal of physiology. Heart and circulatory physiology, 2009, Volume: 297, Issue:6

    Topics: Animals; Antioxidants; Ascorbic Acid; Creatine Kinase; Disease Models, Animal; Female; Glutathione;

2009
Daily reoxygenation decreases myocardial injury and improves post-ischaemic recovery after chronic hypoxia.
    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2010, Volume: 37, Issue:4

    Topics: Animals; Body Weight; Chronic Disease; Hematocrit; Hemoglobins; Hypoxia; Male; Myocardial Infarction

2010
Simvastatin in contrast to postconditioning reduces infarct size in hyperlipidemic rabbits: possible role of oxidative/nitrosative stress attenuation.
    Basic research in cardiology, 2010, Volume: 105, Issue:2

    Topics: Animals; Anticholesteremic Agents; Biomarkers; Cholesterol, LDL; Hemodynamics; Hypercholesterolemia;

2010
Hyperglycemia inhibits anesthetic-induced postconditioning in the rabbit heart via modulation of phosphatidylinositol-3-kinase/Akt and endothelial nitric oxide synthase signaling.
    Journal of cardiovascular pharmacology, 2010, Volume: 55, Issue:4

    Topics: Anesthetics; Animals; Blood Glucose; Blood Pressure; Creatine Kinase, MB Form; Glucose; Heart; Heart

2010
The cardio-protective properties of Ncx-6550, a nitric oxide donating pravastatin, in the mouse.
    Microcirculation (New York, N.Y. : 1994), 2010, Volume: 17, Issue:6

    Topics: Animals; Cardiotonic Agents; Heme Oxygenase-1; Hemodynamics; Hydroxymethylglutaryl-CoA Reductase Inh

2010
Toll-like receptor 4 signaling confers cardiac protection against ischemic injury via inducible nitric oxide synthase- and soluble guanylate cyclase-dependent mechanisms.
    Anesthesiology, 2011, Volume: 114, Issue:3

    Topics: Adaptor Proteins, Vesicular Transport; Animals; Echocardiography; Electrocardiography; Guanylate Cyc

2011
Exercise protects against myocardial ischemia-reperfusion injury via stimulation of β(3)-adrenergic receptors and increased nitric oxide signaling: role of nitrite and nitrosothiols.
    Circulation research, 2011, Jun-10, Volume: 108, Issue:12

    Topics: Adolescent; Adult; Animals; Enzyme Activation; Exercise; Humans; Male; Mice; Mice, Knockout; Myocard

2011
Saying yes to exercise and NO to cardiac injury.
    Circulation research, 2011, Jun-10, Volume: 108, Issue:12

    Topics: Adolescent; Adult; Animals; Enzyme Activation; Exercise; Humans; Male; Mice; Mice, Knockout; Myocard

2011
Is there a trigger role of peroxynitrite in the anti-arrhythmic effect of ischaemic preconditioning and peroxynitrite infusion?
    European journal of pharmacology, 2011, Sep-30, Volume: 667, Issue:1-3

    Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Arterial Occlusive Diseases; Coronary Vessels

2011
Diet-induced obesity suppresses sevoflurane preconditioning against myocardial ischemia-reperfusion injury: role of AMP-activated protein kinase pathway.
    Experimental biology and medicine (Maywood, N.J.), 2011, Volume: 236, Issue:12

    Topics: AMP-Activated Protein Kinases; Anesthetics, Inhalation; Animals; Diet, High-Fat; Ischemic Preconditi

2011
Inhalation of NO during myocardial ischemia reduces infarct size and improves cardiac function.
    Intensive care medicine, 2012, Volume: 38, Issue:8

    Topics: Administration, Inhalation; Animals; Cardiac Output; Cardiotonic Agents; Guanylate Cyclase; Male; Mo

2012
In vivo reduction of reperfusion injury to the heart with apelin-12 peptide in rats.
    Bulletin of experimental biology and medicine, 2011, Volume: 152, Issue:1

    Topics: Animals; Blood Pressure; Cardiotonic Agents; Creatine Kinase, MB Form; Heart Ventricles; Intercellul

2011
Ovariectomy reinstates the infarct size-limiting effect of postconditioning in female rabbits.
    Cell biochemistry and biophysics, 2013, Volume: 65, Issue:3

    Topics: Animals; Coronary Vessels; Estradiol; Female; Hemodynamics; Ischemic Postconditioning; Mitogen-Activ

2013
Role of nitric oxide and free radicals in cardioprotection by blocking Na+/H+ and Na+/Ca2+ exchange in rat heart.
    European journal of pharmacology, 2003, Feb-14, Volume: 461, Issue:2-3

    Topics: Animals; Coronary Circulation; Dose-Response Relationship, Drug; Enzyme Inhibitors; Free Radicals; G

2003
Release of pro-inflammatory mediators during myocardial ischemia/reperfusion in coronary artery bypass graft surgery.
    Molecular and cellular biochemistry, 2003, Volume: 247, Issue:1-2

    Topics: Aged; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Biomarkers; CD4 Antigens; Cell Adhesion

2003
Reduction of nitrite to nitric oxide during ischemia protects against myocardial ischemia-reperfusion damage.
    Proceedings of the National Academy of Sciences of the United States of America, 2004, Sep-14, Volume: 101, Issue:37

    Topics: Animals; Cardiotonic Agents; Humans; Hydrogen-Ion Concentration; Male; Myocardial Ischemia; Myocardi

2004
Inducible nitric oxide synthase contributes to intermittent hypoxia against ischemia/reperfusion injury.
    Acta pharmacologica Sinica, 2005, Volume: 26, Issue:3

    Topics: Animals; Guanidines; Hypoxia; In Vitro Techniques; Male; Myocardial Ischemia; Myocardial Reperfusion

2005
Chronic treatment with rosuvastatin modulates nitric oxide synthase expression and reduces ischemia-reperfusion injury in rat hearts.
    Cardiovascular research, 2005, Jun-01, Volume: 66, Issue:3

    Topics: Animals; Blotting, Western; Capillary Permeability; Creatine Kinase; Drug Administration Schedule; F

2005
Suppression of angioplasty-related inflammation by pre-procedural treatment with trimetazidine.
    The Tohoku journal of experimental medicine, 2006, Volume: 208, Issue:3

    Topics: Aged; Angioplasty, Balloon, Coronary; Biomarkers; C-Reactive Protein; Coronary Disease; Female; Huma

2006
Inhibition of mitochondrial permeability transition prevents sepsis-induced myocardial dysfunction and mortality.
    Journal of the American College of Cardiology, 2006, Jul-18, Volume: 48, Issue:2

    Topics: Animals; Bronchoalveolar Lavage Fluid; Caspases; Cyclosporine; Disease Models, Animal; Immunosuppres

2006
Asymmetric dimethylarginine (ADMA) induces vascular endothelium impairment and aggravates post-ischemic ventricular dysfunction in rats.
    European journal of pharmacology, 2007, Feb-28, Volume: 557, Issue:2-3

    Topics: Acetylcholine; Angiotensin II; Animals; Aorta; Arginine; Blood Pressure; Endothelium, Vascular; Enzy

2007
Delayed 24 hours Nomega-nitro-L-arginine methyl ester injection induces pharmacological cardioprotection against reperfusion injury.
    Cellular and molecular biology (Noisy-le-Grand, France), 2007, Jan-21, Volume: 52 Suppl

    Topics: Adenosine; Animals; Arginine; Blood Pressure; Cardiotonic Agents; Disease Models, Animal; Enzyme Inh

2007
Nitrite augments tolerance to ischemia/reperfusion injury via the modulation of mitochondrial electron transfer.
    The Journal of experimental medicine, 2007, Sep-03, Volume: 204, Issue:9

    Topics: Aconitate Hydratase; Administration, Oral; Animals; Cytochromes c; Cytoprotection; Electron Transpor

2007
Anesthetic preconditioning confers acute cardioprotection via up-regulation of manganese superoxide dismutase and preservation of mitochondrial respiratory enzyme activity.
    Shock (Augusta, Ga.), 2008, Volume: 29, Issue:2

    Topics: Adenosine Triphosphate; Anesthetics; Animals; Decanoic Acids; Hydroxy Acids; Ischemic Preconditionin

2008
Dietary nitrite supplementation protects against myocardial ischemia-reperfusion injury.
    Proceedings of the National Academy of Sciences of the United States of America, 2007, Nov-27, Volume: 104, Issue:48

    Topics: Administration, Oral; Animals; Dietary Supplements; Drug Evaluation, Preclinical; Heme; Mice; Myocar

2007
Polydeoxyribonucleotides and nitric oxide release from guinea-pig hearts during ischaemia and reperfusion.
    British journal of pharmacology, 1995, Volume: 115, Issue:4

    Topics: Acetylcholine; Animals; Arginine; Arrhythmias, Cardiac; Chemical Fractionation; Coronary Circulation

1995
Enzyme-independent formation of nitric oxide in biological tissues.
    Nature medicine, 1995, Volume: 1, Issue:8

    Topics: Animals; Electron Spin Resonance Spectroscopy; Female; Heme; Hydrogen-Ion Concentration; In Vitro Te

1995
Dietary iron alters liver, erythrocyte and plasma antioxidant and nitrite levels, and also sensitizes the heart to ischemia/reperfusion.
    Research communications in molecular pathology and pharmacology, 1997, Volume: 97, Issue:3

    Topics: Animals; Antioxidants; Ascorbic Acid; Catalase; Erythrocytes; Female; Glutathione Peroxidase; Heart;

1997
Nonanticoagulant heparin prevents coronary endothelial dysfunction after brief ischemia-reperfusion injury in the dog.
    Circulation, 1999, Mar-02, Volume: 99, Issue:8

    Topics: Animals; Anticoagulants; Blood Coagulation; Coronary Vessels; Cyclic GMP; Dogs; Endothelium, Vascula

1999
Possible role of cardiac mast cell degranulation and preservation of nitric oxide release in isolated rat heart subjected to ischaemic preconditioning.
    Molecular and cellular biochemistry, 1999, Volume: 199, Issue:1-2

    Topics: Animals; Cell Degranulation; Creatine Kinase; Female; In Vitro Techniques; Ischemic Preconditioning,

1999
Opposite effects of nitric oxide and nitroxyl on postischemic myocardial injury.
    Proceedings of the National Academy of Sciences of the United States of America, 1999, Dec-07, Volume: 96, Issue:25

    Topics: Acetylcholine; Animals; Endothelium, Vascular; Glutathione; Hemodynamics; Male; Myocardial Ischemia;

1999
Chinonin, a novel drug against cardiomyocyte apoptosis induced by hypoxia and reoxygenation.
    Biochimica et biophysica acta, 2000, Feb-21, Volume: 1500, Issue:2

    Topics: Animals; Animals, Newborn; Annexin A5; Apoptosis; Biomarkers; Cell Hypoxia; Cells, Cultured; DNA Fra

2000
Simultaneous intravascular two-dimensional plus Doppler ultrasound is useful for evaluation of postischemic vasodilatation: plasm NOx - levels determined by the Griess method may not reflect the extent of postischemic NO-induced vasodilatation.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2000, Volume: 23, Issue:4

    Topics: Animals; Blood Pressure; Cardiology; Coronary Vessels; Dogs; Echocardiography; Enzyme Inhibitors; Fe

2000
Effect of estrogen on global myocardial ischemia-reperfusion injury in female rats.
    American journal of physiology. Heart and circulatory physiology, 2000, Volume: 279, Issue:6

    Topics: Animals; Calcium; Coloring Agents; Coronary Circulation; Estradiol; Female; In Vitro Techniques; Mic

2000
Possible role of nitric oxide and mast cells in endotoxin-induced cardioprotection.
    Pharmacological research, 2001, Volume: 43, Issue:1

    Topics: Animals; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Canavanine; Cardiovascular Diseases; Cell

2001
Beneficial effects of astringinin, a resveratrol analogue, on the ischemia and reperfusion damage in rat heart.
    Free radical biology & medicine, 2001, Apr-15, Volume: 30, Issue:8

    Topics: Animals; Antioxidants; Free Radical Scavengers; Heart; Hemodynamics; L-Lactate Dehydrogenase; Male;

2001
Simvastatin reduces reperfusion injury by modulating nitric oxide synthase expression: an ex vivo study in isolated working rat hearts.
    Cardiovascular research, 2001, Aug-01, Volume: 51, Issue:2

    Topics: Analysis of Variance; Animals; Blotting, Western; Capillary Permeability; Creatine Kinase; Enzyme In

2001
Cardioprotective effects of acidified sodium nitrite in myocardial ischemia with reperfusion.
    The Journal of pharmacology and experimental therapeutics, 1990, Volume: 252, Issue:1

    Topics: Animals; Blood Pressure; Cats; Coronary Disease; Creatine Kinase; Heart; Heart Rate; Male; Myocardia

1990
Synergism between superoxide dismutase and sodium nitrite in cardioprotection following ischemia and reperfusion.
    American heart journal, 1990, Volume: 119, Issue:3 Pt 1

    Topics: Animals; Cats; Coronary Disease; Creatine Kinase; Drug Synergism; Drug Therapy, Combination; Male; M

1990